Objective Multiple sclerosis (MS) severely affect quality of life (QoL). Pharmacological treatments demonstrated benefits on clinical endpoints, however, without proving a significant effect on QoL, we test the effect of…
Objective Cognitive impairment in multiple sclerosis (MS) is common, present in 40 to 60% of patients, and is under diagnosis. Currently, there is no effective drug and non-pharmacological treatments that…
Objective Fatigue and gait impairment are two of the most common and disabling symptoms in patients with multiple sclerosis (PwMS). If on one side, the gait evaluation of PwMS is…
Objective Fatigue is the most common and disabling symptom among patients suffering from multiple sclerosis (MS). From the initial stages of the disease, a physical deconditioning is also observed among…
Objective Functional performance reflects what an individual does in his/her daily life, providing a crucial dimension of the environmental role on his/her function. The assessment of the functional performance status…
Objective Fampridine is used as a symptomatic treatment in patients with multiple sclerosis (PwMS) gait disorders. Some clinical trials reported a positive effect on cognitive function especially on information-processing speed…
Objective Use of a power wheelchair (PW) can improve quality of life and participation in individuals with mobility impairments. PW skills training is generally seen as insufficient by both clinicians…
Introduction Few data are available on the use of botulinum toxin for spasticity treatment in multiple sclerosis. In a previous study, we found that one of the main therapeutic goals…
Opinion/Feedback/Introduction Stroke is the greatest cause of morbidity in industrialised countries and the third cause of mortality (50,000 deaths per year). The annual incidence is around 300 per 100,000 inhabitants,…
Opinion/Feedback With more than 700,000 patients, chronic obstructive pulmonary disease (COPD), a sickness characterized by a progressive alteration of lungs function, presents a major burden in Canada. Even though COPD…
